Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Bo Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8332-3611; OpenAlex author ID A5031996868. Sources: OpenAlex.

Their work

Papers
13 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2020: 4 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 5 papers · 2025: 2 papers

Papers 13

  1. Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment. First author DOI 10.1016/j.canlet.2025.218016↗
  2. Machine learning based identification of an amino acid metabolism related signature for predicting prognosis and immune microenvironment in pancreatic cancer. Co-author DOI 10.1186/s12885-024-13374-4↗
  3. Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer. First author DOI 10.1016/j.canlet.2024.216649↗
  4. Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gendis.2023.101143↗
  5. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, an… First author DOI 10.1186/s12967-024-05158-y↗
  6. CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. Co-author DOI 10.1186/s13046-024-03201-w↗
  7. Construction of a novel model based on PVT1-MYC duet-related genes for predicting survival and characterization of the tumor microenvironment in pancreatic can… Co-author DOI 10.3389/fimmu.2024.1435593↗
  8. Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. First author DOI 10.1186/s13046-023-02698-x↗
  9. High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis. Co-author DOI 10.1186/s13045-021-01131-0↗
  10. The enhancement of glycolysis regulates pancreatic cancer metastasis. First author DOI 10.1007/s00018-019-03278-z↗
  11. Arginine metabolism: a potential target in pancreatic cancer therapy. Co-author DOI 10.1097/cm9.0000000000001216↗
  12. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Co-author DOI 10.1186/s12943-020-01169-7↗
  13. Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies. Co-author DOI 10.3389/fonc.2020.572722↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei You · 12 shared papers, 2020–2025 · strength 2.04
  2. Yupei Zhao · 11 shared papers, 2020–2025 · strength 1.89
  3. Jie Ren · 7 shared papers, 2023–2025 · strength 1.42
  4. Gang Yang · 7 shared papers, 2020–2024 · strength 1.02
  5. Jinshou Yang · 7 shared papers, 2020–2024 · strength 1.01
  6. Taiping Zhang · 4 shared papers, 2020–2025 · strength 0.67
  7. Xing Wang · 3 shared papers, 2023–2025 · strength 0.60
  8. Yuan Fang · 2 shared papers, 2023–2024 · strength 0.38
  9. Zhe Cao · 1 shared paper, 2025 · strength 0.27
  10. Shijuan Jiang · 1 shared paper, 2025 · strength 0.27
  11. Yuan Chen · 2 shared papers, 2020–2021 · strength 0.24
  12. Ruiyuan Xu · 2 shared papers, 2020–2021 · strength 0.24
  13. Guangyu Chen · 2 shared papers, 2020 · strength 0.23
  14. Xiaohong Liu · 1 shared paper, 2025 · strength 0.22
  15. Xing Wang · 1 shared paper, 2024 · strength 0.21
  16. Xiaohong Liu · 1 shared paper, 2024 · strength 0.20
  17. Ming Cui · 1 shared paper, 2024 · strength 0.20
  18. Xing Wang · 1 shared paper, 2024 · strength 0.20
  19. Tao Liu · 1 shared paper, 2024 · strength 0.16
  20. Jianchun Xiao · 1 shared paper, 2024 · strength 0.16
  21. Jinxin Tao · 1 shared paper, 2024 · strength 0.16
  22. Wenhao Luo · 1 shared paper, 2024 · strength 0.16
  23. Hua Huang · 1 shared paper, 2024 · strength 0.16
  24. Zhe Cao · 1 shared paper, 2024 · strength 0.16
  25. Yifan Fu · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.